A Novel Liver Fibrosis Marker FIB‐5 Index Predicted Response to Cardiac Resynchronization Therapy an...
A Novel Liver Fibrosis Marker FIB‐5 Index Predicted Response to Cardiac Resynchronization Therapy and Prognostic Outcomes in Patients With Heart Failure
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
ABSTRACT
Background
The fibrosis‐5 (FIB‐5) index is a noninvasive marker for assessing the progression of liver fibrosis and predictor in patients with heart failure (HF). This study investigated the association between the FIB‐5 index and response to cardiac resynchronization therapy (CRT) and evaluated its predictive value for prognosis.
Alternative Titles
Full title
A Novel Liver Fibrosis Marker FIB‐5 Index Predicted Response to Cardiac Resynchronization Therapy and Prognostic Outcomes in Patients With Heart Failure
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_875fd5139dd740f883f72e6927bc07c9
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_875fd5139dd740f883f72e6927bc07c9
Other Identifiers
ISSN
1082-720X,1542-474X
E-ISSN
1542-474X
DOI
10.1111/anec.70004
